Memorial Sloan Kettering Cancer Center
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
A Study of Avutometinib for People With Solid Tumor Cancers
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT06104488
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
๐บ๐ธChildren's Healthcare of Atlanta (Data Collection Only), Atlanta, Georgia, United States
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2023-10-25
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 201
- Registration Number
- NCT06099769
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham, Birmingham, Alabama, United States
๐บ๐ธUniversity of California San Francisco (Data collection only), San Francisco, California, United States
๐บ๐ธUniversity of Chicago Medical Center, Chicago, Illinois, United States
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
- Conditions
- Interventions
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 53
- Registration Number
- NCT06083922
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States
๐บ๐ธMemorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
๐บ๐ธMemorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
Study of Radiotherapy and Pembrolizumab in People with Adrenocortical Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2023-10-04
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT06066333
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States
๐บ๐ธMemorial Sloan Kettering Suffolk-Commack, Commack, New York, United States
๐บ๐ธMemorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
- First Posted Date
- 2023-10-04
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT06066346
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
๐บ๐ธMemorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States
๐บ๐ธMemorial Sloan Kettering Cancer Center, New York, New York, United States
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
- Conditions
- Interventions
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 94
- Registration Number
- NCT06057948
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Monmouth (Consent Only), Middletown, New Jersey, United States
๐บ๐ธMemorial Sloan Kettering Bergen (Consent Only), Montvale, New Jersey, United States
๐บ๐ธMemorial Sloan Kettering at Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 64
- Registration Number
- NCT06057935
- Locations
- ๐บ๐ธ
University of Chicago (Data Collection Only), Chicago, Illinois, United States
๐บ๐ธUniversity of Michigan (Data Collection Only), Ann Arbor, Michigan, United States
๐บ๐ธUniversity of Nebraska (Data collection only), Omaha, Nebraska, United States
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM)
- Conditions
- Interventions
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT06055894
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
๐บ๐ธMemorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
๐บ๐ธMemorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
- Conditions
- Interventions
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2024-05-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT06058988
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
- Conditions
- Interventions
- First Posted Date
- 2023-09-14
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT06037941
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only), Commack, New York, United States
๐บ๐ธMemorial Sloan Kettering Westchester (Consent Only), Harrison, New York, United States
๐บ๐ธMemorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States